Comparison of Low-Dose Rosuvastatin with Atorvastatin in Lipid-Lowering Efficacy and Safety in a High-Risk Pakistani Cohort: An Open-Label Randomized Trial
Table 1
Baseline characteristics of study population.
Variable
Atorvastatin group ()
Rosuvastatin group ()
P value
Age (years)
0.494
Gender (M : F)
34 : 29
26 : 40
0.097*
Education (years)
0.019
Current smokers
10 (15.87%)
3 (0.04%)
0.028*
BMI (kg/m2)
0.011
Waist circumference (cm)
0.001
Serum total cholesterol
0.447
Serum triglycerides
0.216
Serum HDL-C
0.071
Serum LDL-C
0.074
By chi-square test; all other P values were calculated by independent samples t-test.